RECURSION PHARMACEUTICALS IN shareholders Q4 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

RECURSION PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 67,871$669,2080.48%
GoalFusion Wealth Management, LLC 20,000$197,2000.13%
BALDWIN BROTHERS LLC/MA 7,336$72,3330.01%
EXCHANGE TRADED CONCEPTS, LLC 16,359$161,3000.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q4 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.